MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Shared Care Guidance

 Shared care protocol for the treatment of attention deficit hyperactivity disorder (ADHD) in children and young people

 Shared care protocol for the treatment of attention deficit hyperactivity disorder (ADHD) in adults

Shared care protocol for prescribing Denosumab for the treatment of osteoporosis

Shared care protocol for non-biologic disease modifying antirheumatic drugs (DMARDs)- Rheumatology, Dermatology, Gastroenterology, Ophthalmology, Respiratory and Neurology (azathioprine, ciclosporin, dapsone, hydroxychloroquine, leflunomide, methotrexate, mercaptopurine, mycophenolate, penicillamine, sulfasalazine, tacrolimus)

 Shared care guideline for prescribing dronedarone (Multaq)

 Shared care guideline for prescribing Grazax - review currently in progress

Shared care guideline - Lithium Treatment Care Pathway, Dec 2022 (review due Dec 2024)

 Shared care guideline for prescribing mercaptopurine in inflammatory bowel disease 

 Shared care guideline for prescribing rifaximin (Targaxan) for hepatic encephalopathy

 Shared care guideline for prescribing riluzole (Rilutek)

 Shared care guideline for prescribing sacubitril/valsartan (Entresto)

Shared care guideline for prescribing Sativex Oromucosal Spray